TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21127721

Group type: EXPERIMENTAL
Intervention: Adolescents encoding positive pictures
Number of subjects: 30

Group type: COMPARATOR
Intervention: Adults encoding positive pictures
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Adolescents encoding negative pictures
Number of subjects: 30

Group type: COMPARATOR
Intervention: Adults encoding negative pictures
Number of subjects: 30
Study: 18324566

Group type: EXPERIMENTAL
Intervention: Smoking Reduction (SR)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: All subjects (regardless of treatment condition)
Number of subjects: 152
Study: 15944869

Group type: EXPERIMENTAL
Intervention: Sibutramine 15 mg o. d. for 3 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antihypertensive treatment
Number of subjects: 0
Study: 12886917

Group type: EXPERIMENTAL
Intervention: ondansetron (0.1 mg x kg‐1)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: cyclizine (20 mg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: placebo (normal saline)
Number of subjects: 150
Study: 10391662

Group type: EXPERIMENTAL
Intervention: HDL-raising therapy
Number of subjects: 2531

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2531
Study: 8872291

Group type: EXPERIMENTAL
Intervention: Walking with 1-lb walking poles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Walking without poles
Number of subjects: 0
Study: 1997698

Group type: EXPERIMENTAL
Intervention: Oral bacillus Calmette-Guerin (BCG)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Intravesical bacillus Calmette-Guerin (BCG)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (transurethral resection only)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Intravesical BCG
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Oral BCG
Number of subjects: 71
Study: 6206321

Group type: EXPERIMENTAL
Intervention: Oral tocainide
Number of subjects: 10

Group type: COMPARATOR
Intervention: Disopyramide
Number of subjects: 10
Study: 30755104

Group type: EXPERIMENTAL
Intervention: Current smoking status
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Longer diabetes duration
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Higher diabetes-related distress
Number of subjects: 282
Study: 29489859

Group type: EXPERIMENTAL
Intervention: Emollients
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control (no emollients)
Number of subjects: 23
Study: 27030325

Group type: EXPERIMENTAL
Intervention: Nebulized budesonide 4 mg/day
Number of subjects: 78

Group type: COMPARATOR
Intervention: Intravenous prednisolone
Number of subjects: 78
Study: 25351025

Group type: EXPERIMENTAL
Intervention: Web-based communication (SG)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Traditional communication (CG)
Number of subjects: 500
Study: 22534712

Group type: EXPERIMENTAL
Intervention: Manual therapy methods applied during a monthly rehabilitation tour
Number of subjects: 40

Group type: COMPARATOR
Intervention: Physical methods of treatment
Number of subjects: 40
Study: 20367417

Group type: EXPERIMENTAL
Intervention: Low-dose teriparatide (20 microg per day)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: High-dose teriparatide (40 microg per day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 17995993

Group type: EXPERIMENTAL
Intervention: Computer-generated tailored letters
Number of subjects: 1499

Group type: EXPERIMENTAL
Intervention: Practitioner-delivered brief advice
Number of subjects: 1499

Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 1499
Study: 15989909

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 5477

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 5477
Study: 12027474

Group type: EXPERIMENTAL
Intervention: haemodynamic optimisation through the use of a pulmonary artery catheter
Number of subjects: 100

Group type: COMPARATOR
Intervention: conventional treatment
Number of subjects: 100
Study: 10348394

Group type: EXPERIMENTAL
Intervention: Shah, Vanclay and Cooper's modified Barthel Index
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Walking speed over 10 metres
Number of subjects: 100
Study: 8551532

Group type: EXPERIMENTAL
Intervention: Continuous vocalization for 30 minutes after botulinum toxin injections
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vocal rest for 30 minutes after botulinum toxin injections
Number of subjects: 20
Study: 1685447

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg three times daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7199332

Group type: EXPERIMENTAL
Intervention: Midazolam (0.2 mg/kg)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Diazepam (0.3 mg/kg)
Number of subjects: 43
Study: 30045355

Group type: EXPERIMENTAL
Intervention: Intranasal Ketamine (1 mg/kg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Intranasal Fentanyl (1.5 μg/kg)
Number of subjects: 22
Study: 31613881

Group type: EXPERIMENTAL
Intervention: Transactional sex participation in the past three months
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Condom use with non-paying partners
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Forced alcohol use at work
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Modern contraception use
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Experiences of gender-based violence
Number of subjects: 600
Study: 29413434

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1200 mg, twice daily
Number of subjects: 302
Study: 26126158

Group type: EXPERIMENTAL
Intervention: Robotic steering and automated lumen centralization (RS-ALC)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional steering
Number of subjects: 18
Study: 25151662

Group type: EXPERIMENTAL
Intervention: Treatment interventions
Number of subjects: 272
Study: 22583627

Group type: EXPERIMENTAL
Intervention: Infrapatellar fat pad-derived mesenchymal stem cell therapy combined with arthroscopic debridement and PRP injection
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (arthroscopic debridement and PRP injection without stem cells)
Number of subjects: 25
Study: 19915976

Group type: EXPERIMENTAL
Intervention: Hormonal treatment for metastatic disease: yes
Number of subjects: 1361

Group type: EXPERIMENTAL
Intervention: Taxanes at first line: yes
Number of subjects: 1361

Group type: EXPERIMENTAL
Intervention: Trastuzumab at first line: yes
Number of subjects: 1361

Group type: COMPARATOR
Intervention: Time period 1995-1998
Number of subjects: 1361

Group type: COMPARATOR
Intervention: Time period 1999-2002
Number of subjects: 1361

Group type: COMPARATOR
Intervention: Time period 2003-2006
Number of subjects: 1361
Study: 18555828

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT+)
Number of subjects: 206

Group type: COMPARATOR
Intervention: No Hormone Replacement Therapy (HRT-)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 206
Study: 16866128

Group type: EXPERIMENTAL
Intervention: Orthodontic appliances
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control groups receiving appropriate treatment
Number of subjects: 0
Study: 12627926

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 2 g in 50 ml of 0.9% sodium chloride
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 20
Study: 10528097

Group type: EXPERIMENTAL
Intervention: Two consecutive doses of 50 microg salbutamol inhaled via Turbuhaler
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Two divided doses of 50 microg salbutamol inhaled via Turbuhaler with 1.5 min between doses
Number of subjects: 17

Group type: COMPARATOR
Intervention: Therapeutic doses of salbutamol via Turbuhaler
Number of subjects: 17
Study: 8921921

Group type: EXPERIMENTAL
Intervention: Nerve conduction studies (NCS) in patients with RA
Number of subjects: 52

Group type: COMPARATOR
Intervention: Nerve conduction studies (NCS) in healthy controls
Number of subjects: 52
Study: 1884725

Group type: EXPERIMENTAL
Intervention: Nifedipine-ER tablets (once daily)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nifedipine capsules (t.d.s.)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nifedipine-ER tablets
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nifedipine capsules
Number of subjects: 24
Study: 6846300

Group type: EXPERIMENTAL
Intervention: Antacid tablets (14 mEq neutralizing capacity per tablet)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 31605880

Group type: EXPERIMENTAL
Intervention: Stature-group-specific equations based on tibial lengths
Number of subjects: 495

Group type: COMPARATOR
Intervention: General equation with all participants of the study group
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Equations tested in cross-validation group for stature <185.9cm
Number of subjects: 495
Study: 30054164

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 577
Study: 28846633

Group type: EXPERIMENTAL
Intervention: Reconstituted freeze-dried strawberry beverage (50 g/day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control beverage
Number of subjects: 17
Study: 26244985

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus bevacizumab (176 patients)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Chemotherapy only (194 patients)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus bevacizumab (high LDH subgroup)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Chemotherapy only (high LDH subgroup)
Number of subjects: 370
Study: 24014834

Group type: EXPERIMENTAL
Intervention: MitraClip therapy
Number of subjects: 881

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 881
Study: 20337570

Group type: EXPERIMENTAL
Intervention: Indirect language therapy delivered by school staff using a consultancy model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manualized language therapy delivered by speech and language therapists or assistants
Number of subjects: 0
Study: 19108423

Group type: EXPERIMENTAL
Intervention: Acupotomy-injection combined with Feng's spinal manipulation (FSM)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Traction (control group)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 72
Study: 16580444

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate administered to increase plasma levels 1(1/2) to 2 times normal during cardiopulmonary bypass, n = 174
Number of subjects: 350

Group type: COMPARATOR
Intervention: No intervention (placebo), n = 176
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 350

Group type: COMPARATOR
Intervention: Magnesium sulfate and placebo
Number of subjects: 350
Study: 14738639

Group type: EXPERIMENTAL
Intervention: HydroThermAblator (HTA)
Number of subjects: 276

Group type: COMPARATOR
Intervention: rollerball (RB)
Number of subjects: 276
Study: 10902991

Group type: EXPERIMENTAL
Intervention: Energy supplement (E) = 1171 kJ + 12 mg iron
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control (M) = 12 mg iron + 209 kJ
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control (S) = 104 kJoule
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control (M) and (S)
Number of subjects: 136
Study: 9127847

Group type: EXPERIMENTAL
Intervention: Brace group (rehabilitation orthosis for 12 weeks postoperatively)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No-brace group (mobilized immediately, crutches discarded 2 weeks postoperatively)
Number of subjects: 60
Study: 8436004

Group type: EXPERIMENTAL
Intervention: Surgical termination of pregnancy
Number of subjects: 113

Group type: COMPARATOR
Intervention: Medical termination of pregnancy with mifepristone (200 mg) and gemeprost (1 mg)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Medical termination of pregnancy with mifepristone (400 mg) and gemeprost (1 mg)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Medical termination of pregnancy with mifepristone (600 mg) and gemeprost (1 mg)
Number of subjects: 113
Study: 2992530

Group type: EXPERIMENTAL
Intervention: suloctidil (Locton) at a daily dose of 200 mg X 3 for 180 days
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: suloctidil (Locton)
Number of subjects: 15
Study: 29970335

Group type: EXPERIMENTAL
Intervention: Closed incision negative pressure therapy (ciNPT)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Standard wound dressings (control group)
Number of subjects: 188
Study: 27866528

Group type: EXPERIMENTAL
Intervention: NIV-NAVA
Number of subjects: 40

Group type: COMPARATOR
Intervention: NIV-PSV
Number of subjects: 40
Study: 26796449

Group type: EXPERIMENTAL
Intervention: Low toric IOL (Acrysof IQ SN6AT3 or SN6AT4)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Moderate-to-high toric IOL (Acrysof IQ SN6AT5, SN6AT6, SN6AT7, SN6AT8, or SN6AT9)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Low toric IOL
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Moderate-to-high toric IOL
Number of subjects: 39

Group type: COMPARATOR
Intervention: Nontoric IOL (Acrysof SN60WF)
Number of subjects: 39
Study: 22891564

Group type: EXPERIMENTAL
Intervention: Radioiodine therapy (average 18.47 +/- 8.81 mCi)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Radioiodine therapy
Number of subjects: 27

Group type: COMPARATOR
Intervention: Thiamazole treatment before radioiodine therapy
Number of subjects: 27
Study: 20306010

Group type: EXPERIMENTAL
Intervention: Clinical trials for surgery
Number of subjects: 2249
Study: 18550953

Group type: EXPERIMENTAL
Intervention: Concurrent strength and endurance (CSE) training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Endurance-only (EO) training
Number of subjects: 16
Study: 16009873

Group type: EXPERIMENTAL
Intervention: H pylori infection (measured by seropositivity) in patients with morbid obesity (181 [43.7%] of 414)
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: H pylori infection in younger age groups (10-19 years)
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: H pylori infection in age group 20-29 years
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: H pylori infection in age group 30-39 years
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: H pylori infection in age group 40 years or older
Number of subjects: 1097
Study: 12421160

Group type: EXPERIMENTAL
Intervention: Acetaminophen 1000 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naproxen 375 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12037844

Group type: EXPERIMENTAL
Intervention: Home prenatal follow-up
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classical hospitalization
Number of subjects: 0
Study: 7584685

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray (FPANS) 200 micrograms once or twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate aqueous nasal spray (BPD) 200 micrograms twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1955610

Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cigarettes
Number of subjects: 20
Study: 88189

Group type: EXPERIMENTAL
Intervention: Audiotape slide programmes with synchronised automated apparatus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Audiotape slide programmes with simple manual equipment
Number of subjects: 0
Study: 30265563

Group type: EXPERIMENTAL
Intervention: RBO1 (4,000 ppm gamma-oryzanol)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: RBO2 (8,000 ppm gamma-oryzanol)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: RBO3 (11,000 ppm gamma-oryzanol)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (soybean oil)
Number of subjects: 59
Study: 27927679

Group type: EXPERIMENTAL
Intervention: Argon laser peripheral iridoplasty (ALPI)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 22
Study: 25646330

Group type: EXPERIMENTAL
Intervention: Breastfeeding (duration and exclusivity categorized into low, intermediate, and high groups)
Number of subjects: 408
Study: 23148551

Group type: EXPERIMENTAL
Intervention: Contingent electrical stimulation (CES)
Number of subjects: 11

Group type: COMPARATOR
Intervention: No CES (placebo)
Number of subjects: 11
Study: 17520566

Group type: EXPERIMENTAL
Intervention: Regional heparinization (heparin 1500 IU/h pre-filter, protamine 15 mg/h post-filter)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Regional citrate anticoagulation (citrate-based replacement fluid 14 mmol/L pre-dilution)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 10
Study: 14979842

Group type: EXPERIMENTAL
Intervention: Internet education intervention (5 Internet documents on quality of care)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internet education intervention with interaction with a nurse
Number of subjects: 0

Group type: COMPARATOR
Intervention: Internet education intervention without interaction with a nurse
Number of subjects: 0
Study: 11114960

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg day-1)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Cholestyramine (6 g three times a day)
Number of subjects: 26
Study: 9339968

Group type: EXPERIMENTAL
Intervention: Notification by patients themselves within 2 days or by disease intervention specialists
Number of subjects: 1966

Group type: EXPERIMENTAL
Intervention: Immediate notification by intervention specialist
Number of subjects: 1966

Group type: EXPERIMENTAL
Intervention: Immediate notification by intervention specialists with option of drawing blood in the field
Number of subjects: 1966

Group type: COMPARATOR
Intervention: All approaches
Number of subjects: 1966
Study: 8264873

Group type: EXPERIMENTAL
Intervention: GnRH (25 micrograms i.v. bolus) during daytime studies
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: GnRH (25 micrograms i.v. bolus) during night studies
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: GnRH (25 micrograms i.v. bolus) during sleep studies
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline (as control) during night studies
Number of subjects: 8
Study: 3792425

Group type: EXPERIMENTAL
Intervention: 11R, 16, 16-trimethyl prostaglandin E2 (TmPGE2)
Number of subjects: 10
Study: 30520111

Group type: EXPERIMENTAL
Intervention: 308-nm excimer laser combined with halometasone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 308-nm excimer laser combined with tacrolimus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 308-nm excimer laser combined with pimecrolimus
Number of subjects: 0

Group type: COMPARATOR
Intervention: 308-nm excimer laser monotherapy
Number of subjects: 0
Study: 29894473

Group type: EXPERIMENTAL
Intervention: Healthy individuals with low educational level
Number of subjects: 99497

Group type: EXPERIMENTAL
Intervention: Healthy individuals who are housewives
Number of subjects: 99497

Group type: EXPERIMENTAL
Intervention: Healthy individuals unable to work
Number of subjects: 99497

Group type: EXPERIMENTAL
Intervention: Healthy individuals perceiving worse health status
Number of subjects: 99497

Group type: EXPERIMENTAL
Intervention: Individuals with chronic disease with low educational level
Number of subjects: 99497

Group type: EXPERIMENTAL
Intervention: Individuals with chronic disease with low household income
Number of subjects: 99497

Group type: EXPERIMENTAL
Intervention: Individuals with chronic disease with ticket exemption
Number of subjects: 99497

Group type: EXPERIMENTAL
Intervention: Individuals with chronic disease with fixed-term occupation
Number of subjects: 99497

Group type: EXPERIMENTAL
Intervention: Former-smokers in both groups
Number of subjects: 99497
Study: 27318749

Group type: EXPERIMENTAL
Intervention: Mechanical CPR on a reducible stretcher (RS-CPR)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Manual CPR on a standard stretcher (SS-CPR)
Number of subjects: 42
Study: 24711149

Group type: EXPERIMENTAL
Intervention: Behavioral weight loss
Number of subjects: 378

Group type: COMPARATOR
Intervention: Structured education programs
Number of subjects: 378
Study: 22864881

Group type: EXPERIMENTAL
Intervention: Robot-assisted colectomy (RAC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Laparoscopically assisted colectomy (LAC)
Number of subjects: 70
Study: 19332518

Group type: EXPERIMENTAL
Intervention: Parotid gland-sparing intensity-modulated radiation therapy (IMRT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional radiotherapy
Number of subjects: 10
Study: 17897465

Group type: EXPERIMENTAL
Intervention: Supervised exercise training four times a week for 12 months
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard treatment alone for 12 months
Number of subjects: 48
Study: 15227764

Group type: EXPERIMENTAL
Intervention: Cultural sensitivity training
Number of subjects: 247

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 247
Study: 11988379

Group type: EXPERIMENTAL
Intervention: bupropion
Number of subjects: 784

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 784
Study: 9793844

Group type: COMPARATOR
Intervention: Nifedipine (20 mg)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Long-term therapy with captopril (75 mg/day, n = 13)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Long-term therapy with nifedipine (40 mg/day, n = 12)
Number of subjects: 31
Study: 7894825

Group type: EXPERIMENTAL
Intervention: Artemether administered intramuscularly twice daily (1.6 or 3.2 mg/kg/day)
Number of subjects: 47
Study: 2558817

Group type: COMPARATOR
Intervention: Soluble insulin 0.15U/kg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ovine CRF41 (oCRF41) 100 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Soluble insulin 0.15U/kg followed by oCRF41 100 micrograms
Number of subjects: 8
Study: 344108

Group type: EXPERIMENTAL
Intervention: Corynebacterium parvum (C.p.) 5 mg/sc/m2 on day 1 in addition to CAO/CMF
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group without C.p.
Number of subjects: 76
Study: 30598342

Group type: EXPERIMENTAL
Intervention: Solriamfetol (300 mg) in fasted condition
Number of subjects: 32

Group type: COMPARATOR
Intervention: Solriamfetol (300 mg) in fed condition
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 32